Radiopharm Theranostics Limited (ASX:RAD)

Riccardo Canevari
MD & CEO
Market Cap (AUD): 44.33M
Sector: Unclassified
Last Trade (AUD): 0.35 -0.03 (-7.89%)
Tab Bar

1. About

Radiopharm Theranostics Limited (ASX:RAD) is a clinical stage radiotherapeutics company targeting some of the largest markets in cancer. 

The Company has a pipeline of four licenced platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development, from some of the world’s leading universities and institutes such as Imperial College London and Memorial Sloan Kettering. 

The assets span all size molecules comprising peptides, fatty acids and antibody targets.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk